WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback